Adalimumab Biosimilar – Anti-TNF alpha mAb – Research Grade

Reference:
Size

100ug, 1mg

Brand

Product type

Clonality

Expression system

Description of Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade

General information about Adalimumab

Adalimumab is a recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases. Check for active clinical trials using this agent.

Product nameAdalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade
SourceDrugBank DB00051
SpeciesHuman
Expression systemMammalian cells
Purity≥90%
SubtypeIgG1
BufferPBS pH7.5
Delivery conditionBlue ice (+4°)
Delivery Time3-5 days if in stock; 3-5 week if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAdalimumab
ReferencePX-TA1001
NoteFor research use only. Not suitable for clinical or therapeutic use.
ClonalityMonoclonal Antibody
SourceDrugBank DB00051
Clear

Contact us to order

+33 (0)3 90 20 54 70

Write us